NEURALSTEM
Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease." Neuralstem's research has allowed them to produce mature, commercial quantities of neural stem cells that can be transplanted into humans as treatments for currently incurable diseases.
NEURALSTEM
Industry:
Biotechnology Health Care Neuroscience Therapeutics
Founded:
1996-01-01
Address:
Rockville, Maryland, United States
Country:
United States
Website Url:
http://www.neuralstem.com
Total Employee:
11+
Status:
Active
Contact:
+30136649606
Total Funding:
39.86 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache ReCAPTCHA ReCAPTCHA V2 AdBlock Acceptable Ads Amazon Ireland Region Symantec Secure Site ASP.NET 2.0 Confluence Networks
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Employees Featured
Founder
Stock Details
Investors List
Tianjin Pharmaceutical Group International Holdings
Tianjin Pharmaceutical Group International Holdings investment in Post-IPO Equity - NeuralStem
Hercules Capital
Hercules Capital investment in Post-IPO Debt - NeuralStem
Official Site Inspections
http://www.neuralstem.com
- Host name: 104.21.71.116
- IP address: 104.21.71.116
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NeuralStem"
Neuralstem, Inc. - Wikipedia
Neuralstem Inc. is a biotechnology company headquartered in Rockville, Maryland that specializes in developing commercial-scale production of multiple types of central nervous system stem cells. In October 2019 Neuralstem announces that the company has changed its name to Seneca Biopharma, Inc. In April 2021 Seneca Biopharma merged with Leading BioSciences to form the combined company Palisade Bio, Inc. See details»
NeuralStem - Crunchbase Company Profile & Funding
Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell …See details»
Neuralstem, Inc. - LinkedIn
Neuralstem, Inc. | 1,126 followers on LinkedIn. Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and ...See details»
Neuralstem Becomes Seneca Biopharma - PR Newswire
GERMANTOWN, Md., Oct. 28, 2019 /PRNewswire/ -- Neuralstem, Inc. (NASDAQ:CUR), announces that the company has changed its name to …See details»
NeuralStem - Funding, Financials, Valuation & Investors
Neuralstem, a biotherapeutics company, aims to apply stem cell research and technology to treat diseases of the central nervous system. New. Resources. ... How much funding has this …See details»
Neuralstem, Inc. - Company Profile & Staff Directory - ContactOut
Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening …See details»
NeuralStem - VentureRadar
Neuralstem is a clinical-stage biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need. Our lead asset, NSI-189, is a new …See details»
Neuralstem - The Org
Neuralstem's patented technology enables the production of neural stem cells of the brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells …See details»
Neuralstem, Inc.: Shareholders Board Members Managers and …
Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is …See details»
NeuralStem - Contacts, Employees, Board Members, Advisors
NeuralStem has 1 current employee profile, Co-Founder, President & CEO I. Richard Garr. I. Richard Garr Co-Founder, President & CEO Browse By: Organizations, People, EventsSee details»
Neuralstem, Inc. Overview | SignalHire Company Profile
Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, ... Organization Website: neuralstem.com : …See details»
Neuralstem - YouTube
Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of ...See details»
Neuralstem Becomes Seneca Biopharma - Nasdaq
GERMANTOWN, Md., Oct. 28, 2019 /PRNewswire/ -- Neuralstem, Inc. (NASDAQ:CUR), announces that the company has changed its name to Seneca Biopharma, Inc. The company …See details»
Neuralstem Announces Plan of Reorganization to Further Align …
May 20, 2016 Neuralstem has completed two clinical studies, in a total of thirty patients, which met primary safety endpoints. In addition to ALS, NSI-566 is also in a Phase 1 study to treat …See details»
A Closer Look At Neuralstem's ALS Treatment - Forbes
Nov 21, 2013 Neuralstem's treatment for amyotrophic lateral sclerosis (ALS), now into Phase 2 clinical trials, is getting more enthusiastic attention. Ted Harada, diagnosed with the disease in …See details»
Company Neuralstem, Inc. Nasdaq - MarketScreener.com
Seneca Biopharma, Inc., formerly Neuralstem, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for diseases of unmet medical need. It is …See details»
NeuralStem - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Mar 30, 2025 NeuralStem uses 6 technology products and services including HTML5, Google Analytics, and Google Fonts, according to G2 Stack. NeuralStem is actively using 4 …See details»
Neuralstem’s Beijing-based Stroke Trial Receives Approval
Sep 28, 2012 We are ready to be the world’s first site for Neuralstem’s cell therapy stroke trial and are excited about its potential,” RuXiang says. According to researchers, the 2-part trial is …See details»
What is Neuralstem? Company Culture, Mission, Values
See what employees say it's like to work at Neuralstem. Salaries, reviews, and more - all posted by employees working at Neuralstem.See details»
NeuralStem - CoBee Company Profile & Funding Rounds
Neuralstem, Inc. is a publicly traded biotherapeutics company. The company aims to apply "stem cell research and its patented human neural stem cell technology to treat diseases of the …See details»